tm
Seeing Is Believing
tm
Seeing Is Believing
KYTX is currently covered by 2 analysts with an average price target of $33. This is a potential upside of $17.93 (291.92%) from yesterday's end of day stock price of $8.42.
Kyverna Therapeutics, Common Stock's activity chart (see below) currently has 17 price targets and 16 ratings on display. The stock rating distribution of KYTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 22.75 days.
Highest price target for KYTX is $33, Lowest price target is $33, average price target is $33.
Most recent stock forecast was given by from WELLS FARGO on 16-Dec-2025. First documented stock forecast 04-Mar-2024.
Currently out of the existing stock ratings of KYTX, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Oct-2025
$33
$24.56 (291.00%)
$31
Buy Since 04-Mar-2024
$33
$24.56 (291.00%)
$25
Hold Since 03-Jul-2024
$5
$-3.44 (-40.76%)
$4
Buy Since 04-Mar-2024
$33
$24.56 (291.00%)
$39
What is KYTX (Kyverna Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on KYTX (Kyverna Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on KYTX (Kyverna Therapeutics, Common Stock)?
Which analyst is the currently most bullish on KYTX (Kyverna Therapeutics, Common Stock)?
Which analyst is the currently most reserved on KYTX (Kyverna Therapeutics, Common Stock)?
